1. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one. Issue 1 (November 2016) Authors: Lundqvist, Andreas; van Hoef, Vincent; Zhang, Xiaonan; Wennerberg, Erik; Lorent, Julie; Witt, Kristina; Sanz, Laia; Liang, Shuo; Murray, Shannon; Larsson, Ola; Kiessling, Rolf; Mao, Yumeng; Sidhom, John-William; Bessell, Catherine; Havel, Jonathan; Schneck, Jonathan; Chan, Timothy; Sachsenmeier, ... Journal: Journal for immunotherapy of cancer Issue: Volume 4:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one. Issue 1 (November 2016) Authors: Lundqvist, Andreas; van Hoef, Vincent; Zhang, Xiaonan; Wennerberg, Erik; Lorent, Julie; Witt, Kristina; Sanz, Laia; Liang, Shuo; Murray, Shannon; Larsson, Ola; Kiessling, Rolf; Mao, Yumeng; Sidhom, John-William; Bessell, Catherine; Havel, Jonathan; Schneck, Jonathan; Chan, Timothy; Sachsenmeier, ... Journal: Journal for immunotherapy of cancer Issue: Volume 4:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one: National Harbor, MD, USA. 9-13 November 2016. (16th November 2016) Authors: Lundqvist, Andreas; van Hoef, Vincent; Zhang, Xiaonan; Wennerberg, Erik; Lorent, Julie; Witt, Kristina; Sanz, Laia Masvidal; Liang, Shuo; Murray, Shannon; Larsson, Ola; Kiessling, Rolf; Mao, Yumeng; Sidhom, John-William; Bessell, Catherine A.; Havel, Jonathan; Schneck, Jonathan; Chan, Timothy A.;... Journal: Journal for immunotherapy of cancer Issue: Volume 4(2016)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 853 Profiling of donor-specific immune effector signatures in response to rituximab in a human whole blood loop assay using blood from CLL patients. (9th November 2020) Authors: Eltahir, Mohamed; Fletcher, Erika; Dynesius, Linn; Jarblad, Justina; Lord, Martin; Olsson, Ida; Zekarias, Mikaela; Yu, Xiaojie; Cragg, Mark; Hammarstom, Caroline; Levedahl, Kerstin Hamberg; Höglund, Martin; Ullenhag, Gustav; Mattsson, Mattias; Mangsbo, Sara Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A906 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 853 Profiling of donor-specific immune effector signatures in response to rituximab in a human whole blood loop assay using blood from CLL patients. (9th November 2020) Authors: Eltahir, Mohamed; Fletcher, Erika; Dynesius, Linn; Jarblad, Justina; Lord, Martin; Olsson, Ida; Zekarias, Mikaela; Yu, Xiaojie; Cragg, Mark; Hammarstom, Caroline; Levedahl, Kerstin Hamberg; Höglund, Martin; Ullenhag, Gustav; Mattsson, Mattias; Mangsbo, Sara Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A508 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Adjuvanted influenza a (H1N1) 2009 vaccine in patients with hematological diseases: good safety and immunogenicity even in chemotherapy‐treated patients. (18th March 2013) Authors: Cherif, Honar; Höglund, Martin; Pauksens, Karlis Journal: European journal of haematology Issue: Volume 90:Number 5(2013:May) Page Start: 413 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Advanced phase chronic myeloid leukaemia (CML) in the tyrosine kinase inhibitor era – a report from the Swedish CML register. (19th August 2016) Authors: Söderlund, Stina; Dahlén, Torsten; Sandin, Fredrik; Olsson‐Strömberg, Ulla; Creignou, Maria; Dreimane, Arta; Lübking, Anna; Markevärn, Berit; Själander, Anders; Wadenvik, Hans; Stenke, Leif; Richter, Johan; Höglund, Martin Journal: European journal of haematology Issue: Volume 98:Number 1(2017:Jan.) Page Start: 57 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Adverse outcomes in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors: Follow‐up of patients diagnosed 2002–2017 in a complete coverage and nationwide agnostic register study. Issue 4 (20th January 2022) Authors: Dahlén, Torsten; Edgren, Gustaf; Ljungman, Per; Flygt, Hjalmar; Richter, Johan; Olsson‐Strömberg, Ulla; Wadenvik, Hans; Dreimane, Arta; Myhr‐Eriksson, Kristina; Zhao, Jingcheng; Själander, Anders; Höglund, Martin; Stenke, Leif Journal: American journal of hematology Issue: Volume 97:Issue 4(2022) Page Start: 421 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Answer to "Letter to the Editor, Scandinavian Journal of Infectious Diseases". (September 2013) Authors: Svensson, Tobias; Cherif, Honar; Höglund, Martin Journal: Scandinavian journal of infectious diseases Issue: Volume 45:Number 9(2013:Sep.) Page Start: 730 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Cardiovascular disease in patients with chronic lymphocytic leukemia: A Swedish nationwide register study with matched comparators. Issue 7 (11th April 2022) Authors: Larsson, Karin; Söderling, Jonas; Höglund, Martin; Glimelius, Ingrid; Mattsson, Mattias Journal: American journal of hematology Issue: Volume 97:Issue 7(2022) Page Start: E255 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗